# MIRA PHARMACEUTICALS, INC. (MIRA) — delisting/forced [announced]
Source: SEC API (secapi.ai) · situation sit_1e00e8a9a7cb1b95fd03 · retrieved 2026-08-11T15:54:00.691Z

## Overview
Mira Pharmaceuticals, Inc. is a pharmaceutical company incorporated in Florida and trading on the Nasdaq Capital Market under the symbol MIRA.

On July 27, 2026, Mira Pharmaceuticals, Inc. received notice from Nasdaq that its common stock failed to maintain the minimum bid price of $1 per share for 30 consecutive business days ended July 24, 2026, violating Nasdaq Listing Rule 5550(a)(2). The company has 180 calendar days, until January 25, 2027, to regain compliance by achieving a closing bid price of at least $1 per share for a minimum of ten consecutive business days. If the company fails to regain compliance within this period, it may be eligible for an additional 180-day cure period if it meets other continued listing standards, or face delisting proceedings.

## Terms
- Counterparty: Nasdaq Stock Market LLC · Price/share: $1

## Key dates
- Announced 2026-07-31 · Expiry 2027-01-25

## Timeline
- 2026-07-31 · 8-K (0001493152-26-035665): 8-K - MIRA PHARMACEUTICALS, INC. — *Mira Pharmaceuticals, Inc. is a pharmaceutical company incorporated in Florida and trading on the Nasdaq Capital Market under the symbol MIRA.* On July 27, 2026, Mira Pharmaceuticals, Inc. received notice from Nasdaq that its common stock failed to maintain the minimum bid price of $1 per share for 30 consecutive business days ended July 24, 2026, violating Nasdaq Listing Rule 5550(a)(2). The company has 180 calendar days, until January 25, 2027, to regain compliance by achieving a closing bid price of at least $1 per share for a minimum of ten consecutive business days. If the company fails to regain compliance within this period, it may be eligible for an additional 180-day cure period if it meets other continued listing standards, or face delisting proceedings.
  https://www.sec.gov/Archives/edgar/data/1904286/0001493152-26-035665.txt

## Citations
- 0001493152-26-035665 — https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&type=&dateb=&owner=include&count=40&search_text=000149315226035665